Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›ChinaAMC›83069

ETF screener

83069

HK0000711199;HK0000744208;HK0000955887

Passive ETF Equity

83069 ETF · ChinaAMC Hang Seng Biotech ETF

The 83069 Exchange Traded Fund (ETF) is provided by ChinaAMC. It is built to track an index: Hang Seng Biotech Index. The 83069 ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. This share class generates a stream of income by distributing dividends.

Last update Yesterday at 1:30 AM UTC

LIVE

CLOSED

This fund is part ofAPAC Blended Cap1M perf.-0.92%

Last price

CN¥11.18

1M perf.

-3.78%

1M flows

-€1.3M

AuM

€224M

TER

0.5%

Rating

Not rated

83069

CN¥11.18

Performance & flows

Segment for quartile rank

March 30, 2026 → June 29, 2026

Create a free account to view the flows graph

83069

HK$13.02

-11.09%

APAC Blended Cap

+22.73%

Historic performance and flows

	1M	3M	1Y	3Y	5Y	MTD	QTD	YTD
Perf.	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Flows

Key fund info

Segment for quartile rank

This ETF's jurisdiction country is not in your region (Europe and Middle East) ·

Main characteristics

Issuer

ChinaAMC

ISIN

HK0000711199

HK0000744208

HK0000955887

AuM

€224M

TER

0.5%

Replication rating

Not rated

More details

NAV

6/29/2026

HK$13.02

1D NAV change

+6.61%

Dividend policy

Distributing

Replication method

Direct (Physical)

Replication model

Full replication

No. of holdings

N/A

Inception date

3/18/2021

Jurisdiction

Hong Kong

Distribution

Hong Kong

Legal structure

Unit Investment Trust

Base currency

HKD

Dividend distribution

Trailing 12-month distr. yield

Distribution frequency

Last distribution

Create a free account to view dividend distribution

Classification

Product type

Passive ETF

Benchmark

Hang Seng Biotech Index

Asset class

Equity

Factors

N/A

Investment strategy

The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Biotech Index.

Tax optimisation

PEA

France

UK Reporting Status

United Kingdom

Create a free Trackinsight Essentials account to unlock insights

Access exclusive metrics and features to support your investment decisions.

New to Trackinsight?

For individual investors

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

More fund data

Compare up to 3 funds

More screener filters

Choose your own screener columns from 100+ metrics

Lists for saving your research

Portfolio construction and analysis

Personal dashboard for live monitoring

For professional investors

Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.

Request a free trial

More professional services:ETF Data Services Due Diligence Services

Risk profile

Segment for quartile rank

Historical risk/return profile

	3M	1Y	3Y	5Y
Returns	-11.10%	-3.17%	+28.67%	-53.92%
Volatility
Perf./Volatility
Max drawdown

Create a free account to view risk/return table

Synthetic Risk and Reward Indicator (SRRI)

UCITS

N/A

PRIIPS

N/A

More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries

Unavailable

100.00%

Sectors

Unavailable

100.00%

Diversification

This fund does not provide direct exposure to underlying securities.

Top 15 holdings

This fund does not provide direct exposure to underlying securities

More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria

SDG

More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:

Not rated

1-year trailing difference

As of June 29, 2026

Create a free account to view the replication graph

83069

N/A

Replication quality

Calculated over 12m, as of June 29, 2026

Tracking error

Tracking difference

1-year cumulative return difference

Best

Worst

Daily return difference

Average

Worst

Replication information

Index

Index ticker

Index dividend policy

Replication method

Replication model

Issuer

ChinaAMC

ChinaAMC ID Card

Number of funds

Total AuM

€4.92B

Expense ratio range

0.15% - 1.2%

Average expense ratio

0.5768%

View all ChinaAMC funds

Top 5 funds by ChinaAMC

		AuM
83188	ChinaAMC CSI 300 Index ETF	€2.28B
83403	ChinaAMC HSI ESG ETF	€1.05B
159957	ChinaAMC SZSE CHINEXT Price Index ETF	€290M
83069	ChinaAMC Hang Seng Biotech ETF	€224M
82839	ChinaAMC MSCI China A 50 Connect ETF	€216M

Frequently asked questions about 83069

What does ChinaAMC Hang Seng Biotech ETF, 83069, invest in?

83069 is a Passive ETF. This ETF provides exposure to Biotechnology Equities.

Which benchmark or index does 83069 replicate?

83069 tracks the Hang Seng Biotech Index - HKD, through a full replication replication method.

What is the Total Expense ratio (TER) of 83069?

83069 carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.

When was 83069 launched?

83069 was introduced to the market on March 18, 2021. It trades on Hong Kong

Who is the ETF issuer of 83069?

ChinaAMC Hang Seng Biotech ETF, 83069, is provided by ChinaAMC. Learn more about ChinaAMC here.

What is the current assets under management (AUM) of 83069?

83069 oversees €224M in assets as of June 29, 2026.

Does 83069 distribute dividends?

83069 follows a distributing dividend policy, meaning it pays out income to investors. As of June 29, 2026, its 12-month trailing yield was 0.38%.

What is the base currency of 83069?

The base currency of 83069 is HKD.

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

83069 ETF · ChinaAMC Hang Seng Biotech ETF

Performance & flows

Historic performance and flows

Monthly performance and flows

Trading and listing info

Key fund info

Essentials

Enterprise

Risk profile

Historical risk/return profile

Exposure

Sustainability

Replication

Issuer

Frequently asked questions about 83069

What does ChinaAMC Hang Seng Biotech ETF, 83069, invest in?

83069 is a Passive ETF. This ETF provides exposure to Biotechnology Equities.

Which benchmark or index does 83069 replicate?

83069 tracks the Hang Seng Biotech Index - HKD, through a full replication replication method.

What is the Total Expense ratio (TER) of 83069?

83069 carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.

When was 83069 launched?

83069 was introduced to the market on March 18, 2021. It trades on Hong Kong

Who is the ETF issuer of 83069?

ChinaAMC Hang Seng Biotech ETF, 83069, is provided by ChinaAMC. Learn more about ChinaAMC here.

What is the current assets under management (AUM) of 83069?

83069 oversees €224M in assets as of June 29, 2026.

Does 83069 distribute dividends?

83069 follows a distributing dividend policy, meaning it pays out income to investors. As of June 29, 2026, its 12-month trailing yield was 0.38%.

What is the base currency of 83069?

The base currency of 83069 is HKD.

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US